OTTAWA, July 3, 2014 /CNW/ - Tweed Marijuana Inc. (TSXV:
TWD) is pleased to announce that its wholly owned subsidiary Tweed
Inc. ("Tweed") is launching collaborative research with researchers
from two leading Canadian universities at its facility in
Smiths Falls, Ontario.
The recently signed Memoranda of Understanding with researchers
from Ryerson University and the
University of Ottawa will contribute
towards building a better knowledge base surrounding medical
marijuana in Canada. "With the new
regulatory system in place, producers and researchers now have the
stability to undertake research not possible in the past," said
Tweed CEO Chuck Rifici. "These
projects will shed insight into everything from ideal growing
conditions to the very question of what makes medical marijuana an
effective medicine."
The first experiments on how environment can affect the health
and productivity of cannabis plants are already underway. "We know
that there are a huge number of environmental factors that can
influence the quality of medical marijuana, and our goal is to
narrow down on some of those key success factors," said Dr.
Lesley Campbell, Assistant Professor
in the Ryerson Department of Chemistry and Biology.
Complementing the work being undertaken with Dr. Campbell, Tweed
has further partnered with academics Cory
Harris, Doug Johnson and
John Arnason at the University of Ottawa to assess correlations between
active ingredients in medical marijuana and strain effectiveness on
selected ailments. "There is an exceptional opportunity to really
start to understand the complex effects of active ingredients in
marijuana," said University of Ottawa
Professor John Arnason. "This work
has the potential to open up entire new avenues of research into
medical marijuana and we look forward to working with Tweed to move
the sector forward."
The research work will be ongoing for the foreseeable future and
will be an important aspect of Tweed's strategic plans.
About Tweed Marijuana Inc.
Tweed Marijuana Inc. is a TSX Venture Exchange listed
company. Its wholly owned subsidiary, Tweed, is a licensed
producer of medical marijuana in Canada. The principal
activities of Tweed are the production and sale of marijuana out of
its facility in Smiths Falls,
Ontario as regulated by the Marihuana for Medical
Purposes Regulations. www.tweed.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Tweed Marijuana Inc.